(Q73085852)
Statements
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders (English)
B Drolet
G Rousseau
P Daleau
R Cardinal
1 October 2000
scientific article published on 01 October 2000